Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia
- PMID: 1164612
- PMCID: PMC1674333
- DOI: 10.1136/bmj.3.5982.511
Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia
Abstract
Evidence is presented that serum creatinine phosphokinase (CPK) activity is of no direct value in screening patients for susceptibility to malignant hyperpyrexia and does not correlate with halothane-induced muscle contracture or the presence of myopathy. Widely differing CPK values were found at different times in the same people. In most "malignant hyperpyrexia" families the susceptible patients had either normal or inconsistently raised CPK values.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources